Moderna MRNA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$3.19B-13.2% | -$2.82B+9.4% | -$3.12B-7.3% | -$2.9B+13.5% | -$3.36B+5.7% | ||
| $235M+9.3% | $215M+3.4% | $208M0.0% | $208M+8.3% | $192M+1.6% | ||
| $472M-2.3% | $483M+1.9% | $474M+2.8% | $461M+4.1% | $443M+3.3% | ||
| —— | —— | —— | —— | —— | ||
| $137M-28.6% | $192M-71.6% | $675M-14.9% | $793M-18.4% | $972M-7.5% | ||
| $1.19B-40.4% | $1.99B— | —— | —— | —— | ||
| —— | $600M+33.3% | $450M+50.0% | $300M+100% | $150M— | ||
| $607M+2.2% | $594M+4,469% | $13M-45.8% | $24M-51.0% | $49M-16.9% | ||
| $283M-57.6% | $668M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Moderna generate?
- Moderna (MRNA) generated -$3.4B in operating cash flow over the trailing twelve months.
- What is Moderna's free cash flow?
- After $137.0M of capital expenditures, Moderna's free cash flow was -$3.6B over the trailing twelve months, up 16.3% year over year.
- Where does Moderna's cash flow data come from?
- Every line is extracted from Moderna's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
